Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting   published : Yesterday    save search
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer
Published: 2024-04-25 (Crawled : 08:00) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
fda anktiva lung positive cancer cell for meeting results
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published: 2024-04-25 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
asco meeting
Rogers Communications Announces Voting Results from Annual and Special Meeting of Shareholders
Published: 2024-04-25 (Crawled : 01:00) - globenewswire.com
RCIAF | $43.5 0% 200 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
RCI | $38.16 -3.61% 0.0% 1.6M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
meeting communications
Cenovus to hold first-quarter conference call and webcast, virtual annual meeting of shareholders on May 1
Published: 2024-04-24 (Crawled : 22:00) - globenewswire.com
CVE | $21.23 -0.19% 0.02% 5.9M twitter stocktwits trandingview |
Energy Minerals
 | Email alert Add to watchlist
conference meeting
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 22:00) - biospace.com/
RCUS 4 | $15.43 -0.45% 0.0% 520K twitter stocktwits trandingview |
Health Technology
 | | O: -0.06% H: 2.32% C: -0.39%
asco arcus meeting
Gran Tierra Energy Inc. Provides Release Date for its 2024 First Quarter Results and Details of Annual Meeting of Stockholders
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
GTE A | $8.26 1.35% 0.0% 300K twitter stocktwits trandingview |
Energy Minerals
 | Email alert Add to watchlist
first energy for meeting results
WEST FRASER ANNOUNCES VOTING RESULTS OF THE ANNUAL SHAREHOLDERS MEETING
Published: 2024-04-24 (Crawled : 21:00) - prnewswire.com
WFG | $78.65 0.05% 0.08% 270K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...
 | Email alert Add to watchlist
west meeting results
MIND Technology Postpones Special Meeting of Preferred Stockholders
Published: 2024-04-24 (Crawled : 21:00) - prnewswire.com
MIND | $4.26 3.94% 47 twitter stocktwits trandingview |
Industrial Services
 | Email alert Add to watchlist
meeting technology
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
MURA | $3.595 -1.78% -1.81% 110K twitter stocktwits trandingview |
| Email alert Add to watchlist
presentation meeting
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BCAB | $2.35 4.91% 4.68% 390K twitter stocktwits trandingview |
| Email alert Add to watchlist
presentation meeting
Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold Annual and Special Meeting on May 2
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FTS | $39.16 0.15% 0.0% 970K twitter stocktwits trandingview |
Utilities
 | Email alert Add to watchlist
first meeting results
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
ERAS | $1.88 -2.59% -2.66% 530K twitter stocktwits trandingview |
| Email alert Add to watchlist
asco meeting
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BDTX | $5.05 0.8% 0.79% 360K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
meeting therapeutics
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
IOBT | $1.455 -1.02% -1.03% 57K twitter stocktwits trandingview |
| Email alert Add to watchlist
biotech presentation for meeting
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FRLN | $6.48 0.0% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease cell meeting parkinson’s therapy
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
KRON | $0.9644 1.52% 1.49% 880K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
kb-0742 update meeting trial
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FGEN | $0.9844 -8.0% -8.7% 2.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
fg-3246 cancer meeting study
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation asco pharmaceuticals for meeting
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation for meeting
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
SNSE | $0.96 -3.78% -3.93% 55K twitter stocktwits trandingview |
| Email alert Add to watchlist
sns-101 asco topline meeting study
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.